Counterfeit drugs, which could contain unchecked and incorrectly dosed ingredients, can pose severe health consequences. In the new issue of Pharma Technology Focus we ask what will it take to implement the European Commission’s Falsified Medicines Directive?
Go deeper with GlobalData
We also review the most recent progress in the study of animal viruses, which has harnessed the avian Newcastle disease virus as a potent cancer killer. We also find out why an astonishing number of doctors in the UK prescribe placebos to their patients on a regular basis, and investigate the dangers of antibiotics being used in farm animals.
We explore the drivers behind the rapid growth of the market for type 2 diabetes treatments, find out how a nano-scale robotic system developed by engineers at the University of Alberta could be used in drug delivery applications, and ask how the drive for innovation in pharmaceutical packaging can be balanced against the need to reduce costs.
Moreover, we look at how developments in drug delivery devices are increasingly focused on easy adherence and pain relief and as new technology emerges we ask if virtual health assistants could be a cost-effective way to improve patient communication and compliance.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataIn this issue
Noble Intentions
The commencement of the European Commission’s Falsified Medicines Directive (FMD) is the latest move to rid Europe of dangerous medicines. Pharma Technology Focus finds out what it will take to implement.
Click here to read the full article.
The Anti-Cancer Virus
Despite the fear surrounding animal-borne disease outbreaks, the study of animal viruses is yielding promising clinical results. We learn about the Avian Newcastle Disease virus being developed as a potent cancer killer.
Click here to read the full article.
Market Insight: Type 2 Diabetes
With the number of people diagnosed with Type 2 diabetes set to double over the next 10 years Dr Valentina Gburcik, GlobalData’s analyst in cardiovascular and metabolic disorders, looks at what this will mean for the pharmaceutical industry.
Click here to read the full article.
Placebo Power
New research has revealed that an astonishing number of UK doctors regularly prescribe placebos to their patients. We ask whether their use should be encouraged in the UK.
Click here to read the full article.
Feeding the Resistance
It’s well known that overusing antibiotics can lead to resistance, but what about those in food? Pharma Technology Focus reports on whether antibiotics used on farms can affect our health.
Click here to read the full article.
Game On
Students at the University of Alberta have pioneered a nano-scale robot. We learn how it could eventually be programmed to navigate the body, administering drugs or destroying cancerous tissue.
Click here to read the full article.
Boxing Clever
Although pharmaceutical packaging is pivotal in improving compliance and reducing counterfeiting, new solutions must be financially viable. Guido Schmitz, Bayer Healthcare, tells us how cost reduction is compromising on creativity.
Click here to read the full article.
Delivering Better Compliance
New developments in drug delivery devices are increasingly focused on patients’ needs, giving priority to easy adherence and reduced pain. Dr Jérôme Freissmuth of Bosch Packaging Technology reviews the recent trends in this sector.
Click here to read the full article.
Virtual Assistance
As new ‘intelligent’ technology emerges, we ask if virtual health assistants could be a cost-effective way to improve patient communication and compliance.
Click here to read the full article.
Next Issue
Scientists have developed statistical models to predict which drug is best for a patient based on a person’s DNA. We find out how this method could help doctors tailor treatments to the individual needs of specific patients.
We also explore breakthroughs in malaria research and catch up with a campaign to eliminate river blindness in Africa and Latin America, as well as finding out about the latest in influenza research from GlobalData.
Moreover, we investigate how changes to GMP guidelines in Europe will affect contract manufacturers and their customers, and take a look at upcoming US and EU regulations which are expected to usher in a new era of manufacturing and distribution compliance in the battle against counterfeits.
Subscribe for free to get each future issue of Pharma Technology Focus delivered directly to your inbox.
Digital Magazine FAQ
The digital magazine is viewable on any computer with Flash Player installed. It is also viewable on mobile devices, iPhones and iPads, although some features and videos may be disabled.
View the archive of back issues.
